Company Filing History:
Years Active: 2022
Title: Innovations by Kristi Lynn Williams
Introduction
Kristi Lynn Williams is a notable inventor based in Chalfont, PA (US). She has made significant contributions to the field of immunology, particularly in the development of methods to induce immunity against respiratory syncytial virus (RSV). Her work is crucial in advancing vaccine technology and improving public health outcomes.
Latest Patents
Kristi Lynn Williams holds one patent titled "Method for the safe induction of immunity against RSV." This patent describes methods of inducing a safe immune response against RSV in a human subject. The process includes administering a composition that contains a recombinant adenovirus with a nucleic acid encoding an RSV Fusion (F) protein. The patent specifies the use of a pharmaceutically acceptable carrier and outlines a total dose ranging from about 1×10 to about 2×10 viral particles (vp).
Career Highlights
Williams is currently associated with Janssen Vaccines & Prevention B.V., where she continues her research and development efforts. Her work focuses on innovative approaches to vaccine development, which are essential in combating viral infections.
Collaborations
Some of her notable coworkers include Myra Noorely Widjojoatmodjo and Olivier Godeaux. Their collaborative efforts contribute to the advancement of vaccine research and development.
Conclusion
Kristi Lynn Williams is a pioneering inventor whose work in vaccine development is making a significant impact in the fight against viral infections. Her innovative methods for inducing immunity against RSV highlight the importance of research in public health.